Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003007140 | SCV002402046 | likely benign | Ocular cystinosis; Juvenile nephropathic cystinosis; Inborn genetic diseases | 2024-03-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004612140 | SCV005105680 | uncertain significance | Inborn genetic diseases | 2024-05-02 | criteria provided, single submitter | clinical testing | The c.80C>A (p.T27N) alteration is located in exon 4 (coding exon 2) of the CTNS gene. This alteration results from a C to A substitution at nucleotide position 80, causing the threonine (T) at amino acid position 27 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005095666 | SCV005641894 | uncertain significance | Ocular cystinosis; Juvenile nephropathic cystinosis; Nephropathic cystinosis | 2024-04-20 | criteria provided, single submitter | clinical testing |